Real World Evidence Director; Patient Safety Data & Analytics

at  AstraZeneca

ELEVATE PATIENT SAFETY AT ASTRAZENECA WITH REAL WORLD DATA EXPERTISE

AstraZeneca seeks a forward-thinking Real World Evidence (RWE) Director to join our dynamic Safety Analytics team within Global Patient Safety. This role is crucial in revolutionizing our approach to detecting and managing safety signals and integrating real-world data (RWD) into the safety signal management process.

As a visionary RWE Director, you will:

• Lead Analytic Solutions: Design and implement cutting-edge analytic solutions using real-world data to solve complex patient safety problems, ensuring the delivery of key insights and strategic value.
• Strategic Partnership and Collaboration: Forge strong partnerships with Safety Epidemiology, drug project teams, and R&D colleagues to support clinical trial diversity and pharmacovigilance analysis, effectively addressing health authority inquiries.
• Drive Real-World Evidence Value: Demonstrate a proven track record in delivering RWE by proposing and implementing data science analyses that address critical business needs, providing expert guidance on study design and data utilization.
• Engage Stakeholders: Engage directly with internal and external stakeholders, understanding their safety-related problems, developing appropriate analytics strategies, and clearly communicating insights and interpretations.
• Develop Data Strategy : Assist in shaping AstraZeneca’s Patient Safety data strategy, evaluating new data providers/vendors, and providing informatics support for data acquisitions.
• Provide Technical Leadership: Offer input on strategic decisions related to data partner selection, risk management, study design, and best practices in the utilization of RWE data.
• Translate Safety Questions into Data Science Problems: Convert unstructured safety questions into definable data science problems, creating analytical solutions and supporting stakeholder discussions to address their questions.
• Evaluate External Data Sources: Assess the strengths and weaknesses of external real-world data sources and potential partners to advance the data strategy for specific therapeutic areas. Respond rapidly to safety-related queries from colleagues and regulators.